Zobrazeno 1 - 10
of 32
pro vyhledávání: '"J D, Horowitz"'
Autor:
S. R. Willoughby, S. Rajendran, W. P. Chan, N. Procter, S. Leslie, E. A. Liberts, T. Heresztyn, Y. Y. Chirkov, J. D. Horowitz
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 8, Iss 4, Pp 595-603 (2015)
Цель. Целями настоящей работы, в которую вошли 2 последовательных исследования в группе больных с высоким сердечно-сосудистым риском с к
Externí odkaz:
https://doaj.org/article/cd841685de0f470896bda7a56583680e
Publikováno v:
Thrombosis research. 181
P2YTo identify clinical correlates of variability in PGIWe compared the inhibitory effects of prostaglandin ECompared to control subjects, patients with ACS and - to a lesser extent - those with SAP, exhibited impaired responses to PGEThe integrity o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4049a72673714351e7e389d67a294a6f
https://pubmed.ncbi.nlm.nih.gov/31376607
https://pubmed.ncbi.nlm.nih.gov/31376607
Autor:
Scott R. Willoughby, S. Leslie, Sharmalar Rajendran, J. D. Horowitz, Y. Y. Chirkov, W. P. Chan, Nathan E.K. Procter, T. Heresztyn, E. A. Liberts
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 8, Iss 4, Pp 595-603 (2015)
Цель. Целями настоящей работы, в которую вошли 2 последовательных исследования в группе больных с высоким сердечно-сосудистым риском с к
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::addcb8caf985ac7aaf061399b27fd15c
https://www.rpcardio.com/jour/article/view/511
https://www.rpcardio.com/jour/article/view/511
Publikováno v:
Journal of internal medicine. 271(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::26e7288cbf7f71e596127c5bdeb42a55
https://pubmed.ncbi.nlm.nih.gov/22061296
https://pubmed.ncbi.nlm.nih.gov/22061296
Publikováno v:
British journal of pharmacology. 166(1)
Renal ischaemia-reperfusion (IR) injury is an inevitable consequence of renal transplantation, causing significant graft injury, increasing the risk of rejection and contributing to poor long-term graft outcome. Renal injury is mediated by cytokine a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e20f73e0efa7d8fd7029468548c934a4
https://pubmed.ncbi.nlm.nih.gov/21745189
https://pubmed.ncbi.nlm.nih.gov/21745189
Publikováno v:
Internal medicine journal. 34(6)
Perhexiline is a prophylactic anti-anginal agent that ameliorates the metabolic basis for myocardial ischaemia and is increasingly used in the management of acute coronary syndromes. No intravenous preparation is available and usual oral loading regi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::835014e26b0e496858486b9df30b820b
https://pubmed.ncbi.nlm.nih.gov/15228400
https://pubmed.ncbi.nlm.nih.gov/15228400
Publikováno v:
Internal medicine journal. 34(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d8ea1c0f9668bcf96b301fe1a1a1e9a6
https://pubmed.ncbi.nlm.nih.gov/15228401
https://pubmed.ncbi.nlm.nih.gov/15228401
Publikováno v:
Internal medicine journal. 33(1-2)
Unfractionated heparin has been pivotal in the management of acute coronary syndromes (ACS), and continues to be used widely despite the emerging role of low molecular weight heparins (LMWH). The apparent superiority of LMWH over unfractionated hepar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1548a5fe1e334492a479409b64acf15f
https://pubmed.ncbi.nlm.nih.gov/14656245
https://pubmed.ncbi.nlm.nih.gov/14656245
Autor:
J G, Cleland, K, Thygesen, B F, Uretsky, P, Armstrong, J D, Horowitz, B, Massie, M, Packer, P A, Poole-Wilson, L, Rydén
Publikováno v:
European heart journal. 22(17)
Aims To determine the sequence of critical cardiovascular events in the progression of heart failure, and whether aetiology or high-dose vs low-dose lisinopril affected these pathways. Methods and Results This was a post-hoc investigation of the ATLA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcb52f5cfa77d463f4b232fee4f4260f
https://pubmed.ncbi.nlm.nih.gov/11492982
https://pubmed.ncbi.nlm.nih.gov/11492982
Autor:
B M, Massie, P W, Armstrong, J G, Cleland, J D, Horowitz, M, Packer, P A, Poole-Wilson, L, Rydén
Publikováno v:
Archives of internal medicine. 161(2)
Treatment with angiotensin-converting enzyme (ACE) inhibitors reduces mortality and morbidity in patients with chronic heart failure (CHF), but most affected patients are not receiving these agents or are being treated with doses lower than those fou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0a9848a99708019a6b1b528f11779ad2
https://pubmed.ncbi.nlm.nih.gov/11176729
https://pubmed.ncbi.nlm.nih.gov/11176729